Xyme
EMEA
Oxford
,
United Kingdom
Startup
FOUNDED
2024
HEADCOUNT
21-100
FUNDING
Undisclosed
Keywords:
enzymes, AI/ML, therapeutics, crop_protection
BUSINESS
Xyme uses generative AI combined with quantum chemistry and experimental data to design novel enzymes for synthetic chemistry, therapeutics, and agricultural applications.
BIOTECH INVOLVEMENT
Biotech is central to the business. Xyme's platform applies generative AI and structural bioinformatics to design enzymes de novo, creating catalysts for chemical reactions that may not exist in nature. The approach fuses protein structure/function modeling with small molecule chemistry and iterative experimental validation.
TECHNOLOGY PLATFORM
generative AI; computational protein/enzyme design
PRIMARY PRODUCTS
AI-generated custom enzymes